Sol-Gel Technologies (SLGL) Projected to Post Quarterly Earnings on Wednesday

Sol-Gel Technologies (NASDAQ:SLGL) is expected to be issuing its quarterly earnings data before the market opens on Wednesday, March 12th. Analysts expect the company to announce earnings of ($0.11) per share and revenue of $2.00 million for the quarter.

Sol-Gel Technologies Stock Performance

NASDAQ SLGL opened at $0.57 on Monday. The business’s 50 day moving average price is $0.82 and its 200-day moving average price is $0.70. The company has a market cap of $15.88 million, a P/E ratio of -1.68 and a beta of 1.29. Sol-Gel Technologies has a fifty-two week low of $0.33 and a fifty-two week high of $1.65.

Sol-Gel Technologies Company Profile

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc, develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea.